168 related articles for article (PubMed ID: 36457093)
1. Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers.
Yang X; Wen X; Guo Q; Zhang Y; Liang Z; Wu Q; Li Z; Ruan W; Ye Z; Wang H; Chen Z; Fan JB; Lan P; Liu H; Wu X
Clin Epigenetics; 2022 Dec; 14(1):160. PubMed ID: 36457093
[TBL] [Abstract][Full Text] [Related]
2. Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA.
Wang W; Zhu X; Zhang X; Lei C; Zeng Z; Lan X; Cui W; Wang F; Xu S; Zhou J; Wu X; Deng H; Li X; Fan J; Ding Y; Huang Z; Liang L
J Pathol; 2023 Apr; 259(4):376-387. PubMed ID: 36573552
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.
Luo H; Zhao Q; Wei W; Zheng L; Yi S; Li G; Wang W; Sheng H; Pu H; Mo H; Zuo Z; Liu Z; Li C; Xie C; Zeng Z; Li W; Hao X; Liu Y; Cao S; Liu W; Gibson S; Zhang K; Xu G; Xu RH
Sci Transl Med; 2020 Jan; 12(524):. PubMed ID: 31894106
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
[TBL] [Abstract][Full Text] [Related]
5. A novel CpG-methylation-based nomogram predicts survival in colorectal cancer.
Wang X; Wang D; Liu J; Feng M; Wu X
Epigenetics; 2020 Nov; 15(11):1213-1227. PubMed ID: 32396412
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer.
Lin WH; Xiao J; Ye ZY; Wei DL; Zhai XH; Xu RH; Zeng ZL; Luo HY
Clin Epigenetics; 2021 Dec; 13(1):232. PubMed ID: 34961566
[TBL] [Abstract][Full Text] [Related]
7. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
8. Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival.
Murray DH; Symonds EL; Young GP; Byrne S; Rabbitt P; Roy A; Cornthwaite K; Karapetis CS; Pedersen SK
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1741-1750. PubMed ID: 29992492
[TBL] [Abstract][Full Text] [Related]
9. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
[No Abstract] [Full Text] [Related]
10. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
[TBL] [Abstract][Full Text] [Related]
11. Differential DNA methylation analysis of
Su JQ; Lai PY; Hu PH; Hu JM; Chang PK; Chen CY; Wu JJ; Lin YJ; Sun CA; Yang T; Hsu CH; Lin HC; Chou YC
World J Gastroenterol; 2022 Feb; 28(8):825-839. PubMed ID: 35317099
[TBL] [Abstract][Full Text] [Related]
12. IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers.
Fu T; Pappou EP; Guzzetta AA; Calmon Mde F; Sun L; Herrera A; Li F; Wolfgang CL; Baylin SB; Iacobuzio-Donahue CA; Tong W; Ahuja N
Ann Surg; 2016 Feb; 263(2):337-44. PubMed ID: 25822686
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
14. CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer.
Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Ahn JB
Yonsei Med J; 2018 Jul; 59(5):588-594. PubMed ID: 29869456
[TBL] [Abstract][Full Text] [Related]
15. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of methylated free circulating DNA in colorectal cancer.
Philipp AB; Stieber P; Nagel D; Neumann J; Spelsberg F; Jung A; Lamerz R; Herbst A; Kolligs FT
Int J Cancer; 2012 Nov; 131(10):2308-19. PubMed ID: 22362391
[TBL] [Abstract][Full Text] [Related]
17. A panel of differentially methylated regions enable prognosis prediction for colorectal cancer.
Zhang L; Li D; Du F; Huang H; Yuan C; Fu J; Sun S; Tian T; Liu X; Sun H; Zhu L; Xu J; Liu Y; Cui B; Zhao Y
Genomics; 2021 Sep; 113(5):3285-3293. PubMed ID: 34302946
[TBL] [Abstract][Full Text] [Related]
18. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
[TBL] [Abstract][Full Text] [Related]
19. A Novel Prognostic DNA Methylation Panel for Colorectal Cancer.
Chung HH; Kuo CC; Hsiao CW; Chen CY; Hu JM; Hsu CH; Chou YC; Lin YW; Shih YL
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547144
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
